Therefore, we propose that monitoring the expression of both MAGEA12 and MAGEA3 may help predict the prognosis and malignancy of breast cancer better than the expression of other members of the MAGE-A family genes. This evidence concerns the gene MAGEA3 and breast carcinoma.